JP Patent

JP2018507915A — エピネフリン製剤

Assigned to Par Pharmaceuticals Inc · Expires 2018-03-22 · 8y expired

What this patent protects

エピネフリンを含む薬剤組成物、投与の方法、その製造方法。組成物は、少なくとも１の活性薬剤、ｐＨ上昇剤、抗酸化物質、遷移金属錯化剤、ｐＨ低下剤、等張化剤、任意に、保存料および、任意に溶媒を含んでもよい。

USPTO Abstract

エピネフリンを含む薬剤組成物、投与の方法、その製造方法。組成物は、少なくとも１の活性薬剤、ｐＨ上昇剤、抗酸化物質、遷移金属錯化剤、ｐＨ低下剤、等張化剤、任意に、保存料および、任意に溶媒を含んでもよい。

Drugs covered by this patent

Patent Metadata

Patent number
JP2018507915A
Jurisdiction
JP
Classification
—
Expires
2018-03-22
Drug substance claim
No
Drug product claim
No
Assignee
Par Pharmaceuticals Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.